Bal Pharma

quarterly
yearly
ParticularsDec '23Mar '24Jun '24Sep '24Dec '24
Revenue81.7596.8173.9475.0573.71
Expenses80.0890.1571.8473.5272.50
EBITDA8.0812.557.897.838.55
EBIT5.5310.795.825.706.21
Profit Before Tax1.686.672.111.521.21
Net Profit1.266.221.751.201.16
Financial Ratios
Operating Profit Margin9.93%13.27%10.79%10.47%11.73%
Net Profit Margin1.55%6.58%2.39%1.61%1.59%
Earning Per Share (Diluted)0.804.181.110.760.73
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2025 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.9.5
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ